Christophe Gerbeau

Statistics

Publications

Citations

631

H-Index

Active since

1996

Affiliations

Novartis (Switzerland)(Current)

Novartis (France)

Medizinische Hochschule Hannover

French Norwegian Foundation

Hôpital d'Hautepierre

Christophe Gerbeau is an author at Novartis (Switzerland) specializing in pharmacokinetics, pharmacokinetics in transplantation, and transplant immunology.

Publications per year

1996–2002

Publications

DISPOSITION OF BASILIXIMAB, AN INTERLEUKIN-2 RECEPTOR MONOCLONAL ANTIBODY, IN RECIPIENTS OF MISMATCHED CADAVER RENAL ALLOGRAFTS1

John M. Kovarik, P. Wolf, J.M. Cisterne et al. · Transplantation · 1997 · 129 citations

Medicine, Immunology, Pharmacology +12

POPULATION PHARMACOKINETICS AND EXPOSURE-RESPONSE RELATIONSHIPS FOR BASILIXIMAB IN KIDNEY TRANSPLANTATION

John M. Kovarik, Barry D. Kahan, P. R. Rajagopalan et al. · Transplantation · 1999 · 90 citations

Medicine, Pharmacokinetics, Pharmacology +14

Successful pregnancy in an infertile woman with a thyrotropin-secreting macroadenoma treated with somatostatin analog (octreotide).

P. Caron, Christophe Gerbeau, Lucien Pradayrol et al. · The Journal of Clinical Endocrinology & Metabolism · 1996 · 68 citations · Full text

Medicine, Endocrinology, Obstetrics +17

Disposition and immunodynamics of basiliximab in liver allograft recipients

John M. Kovarik, Thomas Breidenbach, Christophe Gerbeau et al. · Clinical Pharmacology & Therapeutics · 1998 · 63 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

A rational dosing algorithm for basiliximab (Simulect) in pediatric renal transplantation based on pharmacokinetic-dynamic evaluations1

John M. Kovarik, G. Offner, M. Broyer et al. · Transplantation · 2002 · 53 citations

Medicine, Pediatrics, Pharmacokinetics +17

1–5 of 12